Home
J B Chemicals & Pharmaceuticals Ltd Share Price History
J B Chemicals & Pharmaceuticals Ltd
NSE : 24 Apr, 2025
160014.5 (0.9%)
Prev Close
1585.5
Open Price
1595.0
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
331413
Today's High / Low
1614.0 / 1571.6
52 WK High / Low
2030.0 / 1385.8
Market Price of J B Chemicals & Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Monitoring J B Chemicals & Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 21.74 |
| YoY Gr. | - |
| Net Profit (Cr.) | 184 |
| BVPS | 160.77 |
Key Financial Parameters
| Parameter | 2015 |
|---|---|
| Return on Capital Emp. % | 13.35 |
| Op. Profit Mgn % | 16.48 |
| Net Profit Mgn % | 8.67 |
| Debt to Equity % | 0.11 |
Latest Shareholding
Promoters Holdings Over Time
About J B Chemicals & Pharmaceuticals Ltd
- J B Chemicals & Pharmaceuticals (JBC) was originally promoted and incorporated in Maharashtra by J B Mody as J B Mody Chemicals & Pharmaceuticals in December 18th, 1976.
- The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceuticals formulations, herbal remedies and APIs.
- The company has manufacturing units at Thane, Belapur, Ankleshwar, Panoli and Daman.
- The bulk drug plant at Panoli and formulation plant at Daman became operational in Apr.'95.
- Products like metrogyl, rantac (a ranitidine-based formulation), and nicardia (a cardiac care medicine) form a significant part of the company's sales.
Popular Search
FAQs for J B Chemicals & Pharmaceuticals Ltd Share Price History
What are the key events that typically impact J B Chemicals & Pharmaceuticals Ltd's share price history?
Key events that impact J B Chemicals & Pharmaceuticals Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect J B Chemicals & Pharmaceuticals Ltd's share price history?
Stock splits reduce the nominal price of J B Chemicals & Pharmaceuticals Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of J B Chemicals & Pharmaceuticals Ltd?
Dividends can influence J B Chemicals & Pharmaceuticals Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect J B Chemicals & Pharmaceuticals Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on J B Chemicals & Pharmaceuticals Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand J B Chemicals & Pharmaceuticals Ltd’s share price history?
To understand J B Chemicals & Pharmaceuticals Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
